Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes-Reference-Cited by-同舟云学术

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

Published:2015-07-16 Issue:3 Volume:373 Page:232-242
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Green Jennifer B.,Bethel M. Angelyn,Armstrong Paul W.,Buse John B.,Engel Samuel S.,Garg Jyotsna,Josse Robert,Kaufman Keith D.,Koglin Joerg,Korn Scott,Lachin John M.,McGuire Darren K.,Pencina Michael J.,Standl Eberhard,Stein Peter P.,Suryawanshi Shailaja,Van de Werf Frans,Peterson Eric D.,Holman Rury R.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1501352

Cited by 2178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucose lowering drug or strategy dependent impact of weight reduction on the prevention of CVD outcomes in Type 2 diabetes: a systematic review of CVOTs;Diabetes Research and Clinical Practice;2024-10

2. Effects of switching from dipeptidyl peptidase 4 inhibitors to oral semaglutide on oxidative stress and glycemic variability in patients with type 2 diabetes: an open-label, prospective, randomized, multicenter, parallel-group comparison study;2024-09-09

3. Agreement Between Mega-Trials and Smaller Trials;JAMA Network Open;2024-09-06

4. Factor affecting severe atherothrombotic cerebral infarction in patients with type 2 diabetes mellitus: Large‐scale claim database analysis of Japan;Journal of Diabetes Investigation;2024-09-05

5. The use of composite endpoints in cardiovascular outcome trials for diabetes: A review of 22 randomized clinical trials published since 2008;Diabetes, Obesity and Metabolism;2024-09-02